We are live on
!
Find out more
Alkeon Capital Management Portfolio holdings
AUM
$59.5B
1-Year Est. Return
51.63%
This Fund
S&P 500
This Quarter
Est. Return
+11.01%
1 Year Est. Return
+51.63%
3 Year Est. Return
+162.63%
5 Year Est. Return
+168.42%
10 Year Est. Return
+1,374.92%
AUM
$54B
AUM Growth
+$14.5B
(+37%)
Cap. Flow
+$10.7B
Cap. Flow
% of AUM
19.86%
Top 10 Holdings %
Top 10 Hldgs %
63.09%
Holding
166
New
21
Increased
55
Reduced
22
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$285M |
| 2 |
Pinterest
PINS
|
+$235M |
| 3 |
CoStar Group
CSGP
|
+$221M |
| 4 |
Meta Platforms (Facebook)
META
|
+$181M |
| 5 |
TJX Companies
TJX
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$242M |
| 2 |
Mercado Libre
MELI
|
+$165M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
+$164M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$94.8M |
| 5 |
Boeing
BA
|
+$91.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.16% |
| 2 | Consumer Discretionary | 7.33% |
| 3 | Communication Services | 3.81% |
| 4 | Financials | 3.2% |
| 5 | Healthcare | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Micron Technology
MU
$994B
| $48.8M | 0.09% |
1,039,697
+509,697
| +96% | +$24.7M |
|
102
RTX Corp
RTX
$303B
| $47.1M | 0.09% |
818,196
-260,000
| -24% | -$15.8M |
|
103
Unity
U
$18.6B
| $43.6M | 0.08% |
+500,000
| New | +$42.2M |
|
|
TPTX
104
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $41.7M | 0.08% |
477,000
| – | – |
|
105
CALL
Carnival Corporation Ltd
CCL
$38.7B
| $38M | 0.07% |
2,500,000
+1,500,000
| +150% | +$23.2M |
|
|
ALTR
106
DELISTED
Altair Engineering Inc
ALTR
| $36.7M | 0.07% |
875,000
| – | – |
|
107
Microchip Technology
MCHP
$44.3B
| $36.5M | 0.07% |
710,000
-90,000
| -11% | -$4.68M |
|
108
Parsons
PSN
$4.93B
| $35.2M | 0.07% |
1,050,093
+10,900
| +1% | +$377K |
|
109
Snowflake
SNOW
$116B
| $35.1M | 0.07% |
+140,000
| New | +$33.3M |
|
|
DCPH
110
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $34.4M | 0.06% |
670,975
| – | – |
|
111
Karyopharm Therapeutics
KPTI
$46.2M
| $31.6M | 0.06% |
144,327
+6,667
| +5% | +$1.63M |
|
|
KLRS
112
Kalaris Therapeutics
KLRS
$94.7M
| $30.2M | 0.06% |
+47,696
| New | +$32.6M |
|
|
MRSN
113
DELISTED
Mersana Therapeutics
MRSN
| $28.9M | 0.05% |
+62,000
| New | +$31.3M |
|
114
Take-Two Interactive
TTWO
$47.4B
| $28.6M | 0.05% |
173,222
-172,800
| -50% | -$28.1M |
|
115
Zoom
ZM
$31.2B
| $28.2M | 0.05% |
60,000
| – | – |
|
|
RNAM
116
DELISTED
Avidity Biosciences
RNAM
| $24.6M | 0.05% |
875,000
+100,000
| +13% | +$2.89M |
|
117
CALL
American Airlines Group
AAL
$10.2B
| $24.6M | 0.05% |
2,000,000
| – | – |
|
118
American Well
AMWL
$237M
| $23.7M | 0.04% |
+40,000
| New | +$21.1M |
|
119
Datadog
DDOG
$91.5B
| $22M | 0.04% |
215,000
+40,000
| +23% | +$3.48M |
|
120
PUT
Weibo
WB
$1.96B
| $18.2M | 0.03% |
500,000
| – | – |
|
121
PMV Pharmaceuticals
PMVP
$62.9M
| $16.9M | 0.03% |
+475,000
| New | +$17.5M |
|
|
APLT
122
DELISTED
Applied Therapeutics
APLT
| $15.3M | 0.03% |
738,039
| – | – |
|
123
Beam Therapeutics
BEAM
$2.82B
| $12.3M | 0.02% |
500,000
| – | – |
|
124
Arcus Biosciences
RCUS
$3.63B
| $12.3M | 0.02% |
714,845
+100,000
| +16% | +$2.23M |
|
125
PayPal
PYPL
$50.1B
| $9.51M | 0.02% |
48,281
| – | – |
|
Similar funds
QCM
NAMI
Alkeon Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Alkeon Capital Management held 166 positions worth $54B, up 37% from $39.5B the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Alkeon Capital Management deployed $10.7B of net new capital in Q3 2020, opening 21 new positions and adding to 55 existing holdings. Its largest new stake was Salesforce: 1,300,000 shares worth $327M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Apple, an estimated $242M trimmed.
- Alkeon Capital Management's largest Q3 2020 buy was Salesforce: 1,300,000 shares worth $327M.
- Alkeon Capital Management added most to CoStar Group in Q3 2020, an estimated $221M increase.
- Alkeon Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $242M.
- Alkeon Capital Management fully exited Immunomedics Inc in Q3 2020, selling an estimated $164M.
- Alkeon Capital Management's ten largest holdings make up 63% of its $54B portfolio in Q3 2020.
- Alkeon Capital Management opened 21 new positions and closed 21 in Q3 2020.
- Alkeon Capital Management's portfolio value rose 37% quarter-over-quarter to $54B.
Based on Alkeon Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.